Provider

President of Included Health Robin Cherry Glass sat down with MobiHealthNews to discuss the company's offerings and activities during the JPM Healthcare Conference.

The funds will be used to increase product offerings, expand the commercial team and move into the substance use disorder space.  

Neurotechnology company, Grey Matter Neurosciences, announced it secured $14 million in seed financing, which will be used to develop an ultrasound headset for individuals with Alzheimer's disease and test that device in clinical trials.

Patients are interested in AI to try and garner more information about their care or their child's care. Tools like ChatGPT are being utilized more by patients, says Dr. Samuel Browd of UW and Seattle Children's and the CMO at Proprio.

PanopticAI also claims to be the first in the city to obtain US FDA clearance for software as a medical device.

The multifunctional biomedical robot can do imaging, sampling, and laser ablation.   

The company will use the funds to scale operations and accelerate its innovation and commercialization initiatives.

The company will use the funds to expand access to its hormonal healthcare platform across the U.S.

The company, in partnership with Microsoft, aims to develop cancer medicines, followed by treatments for autoimmune diseases and rare conditions.

AI models used to enhance cybersecurity include supervised, unsupervised machine learning and genAI that can take complex data and distill it down to something human-readable, says Etay Maor, Cato Networks' chief security strategist.